BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4163993)

  • 1. Erythrocyte lipids in Tay-Sachs disease.
    Booth DA
    Lancet; 1967 Mar; 1(7490):626. PubMed ID: 4163993
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of red cell stromal proteins in Tay-Sachs disease.
    Balint JA; Kyriakides EC
    J Clin Invest; 1968 Aug; 47(8):1858-64. PubMed ID: 5666115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic acid in erythrocytes of patients with amaurotic idiocy and Huntington's chorea.
    Pronk JC; Hooyen-Bosma E; Edgar GW
    Humangenetik; 1972; 17(1):65-8. PubMed ID: 4265109
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Triton X-100 on electrophoretic mobility of red blood cell ghosts from normal individuals and patients with Tay-Sachs disease.
    Pourfar M; Levy S
    Clin Chem; 1971 Apr; 17(4):332-4. PubMed ID: 4101583
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipids in blood plasma and erythrocytes in juvenile amaurotic idiocy. Cholestyramine therapy.
    van Creveld S; Hooghwinkel GJ
    Arch Neurol; 1967 Sep; 17(3):225-9. PubMed ID: 6053565
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding Tay-Sachs disease. Recent advances.
    Volk BW
    Clin Pediatr (Phila); 1966 Nov; 5(11):653-4. PubMed ID: 5926922
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES OF RED-CELL STROMAL LIPIDS IN TAY-SACHS DISEASE AND OTHER LIPIDOSES.
    BALINT JA; SPITZER HL; KYRIAKIDES EC
    J Clin Invest; 1963 Nov; 42(11):1661-8. PubMed ID: 14083158
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies inn Tay-Sachs disease. V. The membrane of the membranous cytoplasmic body.
    TERRY RD; KOREY SR
    J Neuropathol Exp Neurol; 1963 Jan; 22():98-104. PubMed ID: 13980700
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormality of cerebral neutral lipids and glycolipids in a case of Tay-Sachs disease which appeared in siblings.
    Taketomi T; Kawamura N; Okano A
    Jpn J Exp Med; 1971 Apr; 41(2):103-11. PubMed ID: 5313762
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biochemical study of cerebral and hepatic lipids in a case of Tay-Sachs disease].
    Grégoire PE; Jonniaux G; Loeb H; Voet W; Capelle R
    Rev Fr Etud Clin Biol; 1969; 14(6):568-74. PubMed ID: 5824260
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
    Tallman JF; Johnson WG; Brady RO
    J Clin Invest; 1972 Sep; 51(9):2339-45. PubMed ID: 4639018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of human erythrocyte neuraminic acid: relationship to haemolysis and red blood cell virus interaction.
    YACHNIN S; GARDNER FH
    Br J Haematol; 1961 Oct; 7():464-75. PubMed ID: 14008670
    [No Abstract]   [Full Text] [Related]  

  • 13. TAY-SACHS DISEASE WITH VISCERAL INVOLVEMENT AND ITS RELATION TO GARGOYLISM.
    NORMAN RM; TINGEY AH; NEWMAN CG; WARD SP
    Arch Dis Child; 1964 Dec; 39(208):634-40. PubMed ID: 14230761
    [No Abstract]   [Full Text] [Related]  

  • 14. Tay-sachs disease.
    Brady RO
    N Engl J Med; 1969 Nov; 281(22):1243-4. PubMed ID: 5347842
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the erythrocyte content of neuraminic acid and enzyme activity in experimental staphylococcal infection].
    Zakharova NB; Kashtanova TN
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (1):20-3. PubMed ID: 6460532
    [No Abstract]   [Full Text] [Related]  

  • 16. [On a component of the mixture of brain gangliosides, which is transferred to the Tay-Sachs ganglioside under the influence of neuraminidase].
    Klenk E; Naoi M
    Hoppe Seylers Z Physiol Chem; 1968 Mar; 349(3):288-92. PubMed ID: 4302220
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on brain lipids in Tay-Sachs' disease. III. Solubility properties of gangliosides.
    GATT S; BERMAN ER
    J Neurochem; 1963 Feb; 10():65-72. PubMed ID: 13946798
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on brain lipids in Tay-Sachs' disease. II. Solubility properties of gangliosides.
    GATT S; BERMAN ER
    J Neurochem; 1963 Feb; 10():65-72. PubMed ID: 13946797
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycoprotein response to open-heart surgery.
    Wallace HW; Arai K; Blakemore WS
    J Thorac Cardiovasc Surg; 1970 Mar; 59(3):376-81. PubMed ID: 5415084
    [No Abstract]   [Full Text] [Related]  

  • 20. FORMATION OF THE MEMBRANOUS CYTOPLASMIC BODIES OF TAY-SACHS DISEASE.
    SAMUELS S; GONATAS NK
    Trans Am Neurol Assoc; 1963; 88():267-9. PubMed ID: 14272253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.